肺癌筛查资格中的性别差异:USPSTF与PLCOm2012标准比较
该回顾性分析基于芝加哥CREST队列883例肺癌病例,比较USPSTF 2013/2021与PLCOm2012风险模型的筛查敏感性。USPSTF标准下女性敏感性低于男性,PLCOm2012阈值下性别差异无统计学意义,提示风险模型可减弱性别差异。
要点
- USPSTF 2021敏感性高于2013,但女性仍低于男性
- PLCOm2012风险模型可提高敏感性并减弱性别差异
- 女性因吸烟量<20包年更易被USPSTF 2021排除
核心结论
- USPSTF 2021资格标准较2013更敏感,但性别差异仍存在。
- 在USPSTF指南中加入PLCOm2012风险预测模型可提高敏感性并减弱性别差异。
研究设计与样本
- 回顾性分析芝加哥CREST队列883例肺癌病例,按性别分层比较USPSTF与PLCOm2012标准的敏感性。
- PLCOm2012分别采用≥1.7%/6年(对比USPSTF 2013)和≥1.0%/6年(对比USPSTF 2021)阈值。
主要发现
- USPSTF 2013敏感性女性46.7%、男性64.6%(P = .003)。
- USPSTF 2021敏感性女性56.8%、男性71.8%(P = .02)。
- PLCOm2012 ≥ 1.7%/6y敏感性女性64.6%、男性70.4%;≥ 1.0%/6y女性77.4%、男性82.4%。
- PLCOm2012两个阈值的性别敏感性差异均无统计学意义(均P = .07)。
- 女性因吸烟暴露<20包年而不符合USPSTF 2021的比例为22.8%,男性为14.8%(ORWomen vs Men 1.70;95% CI 1.19-2.44;P = .002),其中27%不符合的女性符合PLCOm2012 ≥ 1.0%/6y标准。
关键数值与推荐
- USPSTF 2013敏感性:女性46.7%,男性64.6%(P = .003)。
- USPSTF 2021敏感性:女性56.8%,男性71.8%(P = .02)。
- PLCOm2012 ≥ 1.7%/6y敏感性:女性64.6%,男性70.4%(P = .07)。
- PLCOm2012 ≥ 1.0%/6y敏感性:女性77.4%,男性82.4%(P = .07)。
- 吸烟<20包年导致不符合USPSTF 2021:女性22.8% vs 男性14.8%(OR 1.70;95% CI 1.19-2.44;P = .002)。
临床怎么用
- 对吸烟暴露<20包年的女性,可考虑用PLCOm2012风险模型评估筛查资格以减少漏筛。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lung cancer is the leading cause of cancer death in women in the United States. Prospective randomized lung screening trials suggest a greater lung cancer mortality benefit from screening women compared with men. RESEARCH QUESTION: Do the United States Preventative Services Task Force (USPSTF) lung screening guidelines that are based solely on age and smoking history contribute to sex disparities in eligibility, and if so, does the use of the PLCOm2012 risk prediction model that is based on 11 predictors of lung cancer reduce sex disparities? STUDY DESIGN AND METHODS: This retrospective analysis of 883 lung cancer cases in the Chicago Race Eligibility for Screening Cohort (CREST) determined the sensitivity of USPSTF vs PLCOm2012 eligibility criteria, stratified according to sex. For comparisons vs the USPSTF 2013 and the recently published USPSTF 2021 (released March 9, 2021) eligibility criteria, the PLCOm2012 model was used with risk thresholds of ≥ 1.7%/6 years (6y) and ≥ 1.0%/6y, respectively. RESULTS: The sensitivities for screening by the USPSTF 2013 were 46.7% for women and 64.6% for men (P = .003) and by the USPSTF 2021 were 56.8% and 71.8%, respectively (P = .02). In contrast, the PLCOm2012 ≥ 1.7%/6y sensitivities were 64.6% and 70.4%, and the PLCOm2012 ≥ 1.0%/6y sensitivities were 77.4% and 82.4%. The PLCOm2012 differences in sensitivity using ≥ 1.7%/6y and ≥ 1.0%/6y thresholds between women and men were nonsignificant (both, P = .07). Compared with men, women were more likely to be ineligible according to the USPSTF 2021 criteria because their smoking exposures were < 20 pack-years (22.8% vs 14.8%; ORWomen vs Men, 1.70; 95% CI, 1.19-2.44; P = .002), and 27% of these ineligible women were eligible according to the PLCOm2012 ≥ 1.0%/6y criteria. INTERPRETATION: Although the USPSTF 2021 eligibility criteria are more sensitive than the USPSTF 2013 guidelines, sex disparities in eligibility remain. Adding the PLCOm2012 risk prediction model to the USPSTF guidelines would improve sensitivity and attenuate sex disparities.
引用
- Pasquinelli MM, Tammemägi MC, Kovitz KL, et al. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria. Chest. 2021. PMID: 34252436. doi:10.1016/j.chest.2021.06.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。